US Edition
Demethylzeylasteral Blocks Pancreatic Cancer via MESP1 Suppression
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.4 Articles
4 Articles
Breakthrough in Pancreatic Cancer: Experimental Drug AMP945
Breakthrough AMP945 Cancer Remission body { font-family: Georgia, serif; line-height: 1.8; background: #fff; color: #111; margin: 0; padding: 2em; } .container { max-width: 1400px; width: 95%; margin: auto; } h1, h2 { text-align: center; } iframe { width: 100%; height: 100%; border: none; } .video-wrapper { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; border-radius: 12px; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15); m…
Pancreatic cancer usually builds a kind of wall around it. A dense, fibrous layer, full of cells and substances at its service, that helps it isolate itself and hide from the immune system to continue growing without stopping. Thus it survives. That microenvironment, called stroma, represents, in fact, most of the tumor and is responsible, among other factors, for the extreme aggressiveness of this disease: the survival at the age of five years …
Researchers at the Aragón Health Research Institute (IIS Aragón) have discovered a new pathway that could slow the progression of pancreatic cancer and its ability to metastasize. This discovery opens up new therapeutic possibilities for one of the most aggressive and difficult-to-treat tumors. Pancreatic cancer has a high mortality rate and is diagnosed in most cases at very advanced stages. This important discovery has just been published in t…
Demethylzeylasteral Blocks Pancreatic Cancer via MESP1 Suppression
In a groundbreaking advancement in the fight against pancreatic cancer, researchers have illuminated a novel molecular pathway that could pave the way for transformative therapeutic strategies. Pancreatic cancer remains one of the deadliest malignancies worldwide, often diagnosed late and resistant to conventional treatments. The latest study, conducted by Ma, Cheng, Jia, and colleagues, uncovers the […]
Coverage Details
Bias Distribution
- 100% of the sources lean Right
To view factuality data please Upgrade to Premium
